Clinical Trials Browser

Phase 1 × Alzheimer Disease × Clear all

NCT06644573 2025-05-28

PSHW

Phase 1 Not yet recruiting

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

NCT05328115 2025-01-31

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Phase 1 Completed

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT02859207 2017-06-08

A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Phase 1 Completed

Alzheimer Disease, Lymphoma, Follicular

NCT00411580 2013-03-29

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Phase 1 Completed

Alzheimer Disease, Lymphoma, Follicular